News

Conquer Cancer®, the ASCO Foundation, joins ASCO in congratulating the recipients of the 2024 ASCO Special Awards. These awards, to be presented at the 2024 ASCO Annual Meeting, recognize researchers, patient advocates, philanthropists, teachers, and global oncology leaders who have reshaped cancer care around the world.

The 2024 ASCO Special Awards are generously supported by:

ALEXANDRIA, Va. – Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2024 ASCO Annual Meeting Merit Awards. 

Annual Meeting Merit Awards support students and trainees who are first authors on abstracts selected for presentation at the ASCO Annual Meeting. This year, Conquer Cancer will recognize 138 recipients with Merit Awards. These recipients are recognized for their respective field and research advancements within the cancer care community.   

Alexandria, Va. — Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of two mentorship awards distributed through the Women Who Conquer Cancer initiative.

Sharon H. Giordano, MD, MPH, FASCO, will receive the Hologic, Inc., Endowed Women Who Conquer Cancer Mentorship Award. Ines Vaz-Luis, MD, PhD, will receive the 2024 International Women Who Conquer Cancer Mentorship Award recipient.

Alexandria, Va. — Conquer Cancer®, the ASCO Foundation, welcomes two new members to its Board of Directors.

Bill Behnke and Otis Webb Brawley, MD, MACP, FASCO will help guide Conquer Cancer as it works toward its vision of a world where cancer is prevented or cured, and every survivor is healthy.

ALEXANDRIA, Va. — Conquer Cancer®, the ASCO Foundation, in collaboration with the Carson Leslie Foundation (CLF) #cureMEdullo, has awarded the Carson Leslie Foundation #cureMEdullo Team Science Grant in Medulloblastoma powered by EveryGrant® to a group of researchers at Sidney Kimmel Cancer Center/Johns Hopkins Medicine. The recipients will study a new approach for reducing the risk of cerebellar mutism syndrome (CMS) and neurocognitive outcomes following CMS in pediatric patients with medulloblastoma.

Conquer Cancer®, the ASCO Foundation, in collaboration with Pfizer Global Medical Grants, announced two new grants totaling $1,000,000 to support quality improvement projects to address disparities in delivery of care and treatment outcomes for patients of color with metastatic breast cancer (mBC).